Medications

New anti-cholesterol drugs too expensive: report

The high price of two new anti-cholesterol drugs limits the benefits patients may see from them, according to a draft report released Wednesday by a US nonprofit examining drug cost effectiveness.

Medications

A pharmacist explains why drugs cost so much

When a nationally prominent oncologist said "drugs cost too much" during a high-profile speech at the annual meeting of the American Society of Clinical Oncology recently, no one was particularly shocked. The cost of new ...

Oncology & Cancer

Current blood cancer drug prices not justified, study finds

The costs associated with cancer drug prices have risen dramatically over the past 15 years, which is of concern to many top oncologists. In a new analysis, researchers at The University of Texas MD Anderson Cancer Center ...

Medications

Prices of cancer drugs have soared since 1995, study finds

The prices of leading cancer drugs have risen at rates far outstripping inflation over the last two decades, according to a new study co-authored by an MIT economist—but the exact reasons for the cost increases are unclear.

Oncology & Cancer

Disappointment as breast cancer drug not approved on NHS

The breast cancer drug trastuzumab emtansine (also known as Kadcyla) will not be made routinely available on the NHS following a failure to reach an agreement on price between the National Institute for Health and Care Excellence ...

page 14 from 22